Navigation Links
Genomas to Present at Life Sciences & Healthcare Venture Summit
Date:10/29/2008

HARTFORD, Conn., Oct. 29 /PRNewswire/ -- Genomas(R) today announced that Gualberto Ruano, MD, PhD, President and CEO, will present at the Life Sciences & Healthcare Venture Summit in New York City on October 30, 2008 at 11:40 a.m. ET. Dr. Ruano's presentation, Bringing DNA-Guided Medicine to the Clinic, will include a corporate overview and an update on the Company's programs in cardiovascular medicine (statins) and psychiatry (atypical antipsychotics).

The Life Sciences & Healthcare Venture Summit connects emerging biotech, pharmaceutical, healthcare, medical device and diagnostic companies with venture capitalists, angel investors and corporate venture capital. Genomas is one of 40 companies selected to present at the 2008 conference.

ABOUT GENOMAS

Genomas(R) Inc. is a biomedical company advancing DNA-guided medicine and personalized healthcare. The company develops revolutionary PhyzioType(TM) Systems for DNA-guided diagnosis and prevention of metabolic disorders induced by drugs in cardiovascular and psychiatric medicine. PhyzioType Systems are designed to provide physicians with an unprecedented capability to select for each patient the safest drug treatment to enhance compliance. Genomas is located in Hartford, CT on the campus of Hartford Hospital. Please visit http://www.genomas.net for more information.


'/>"/>
SOURCE Genomas
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
2. Genomas Awarded $1.2 Million NIH SBIR Grant to Develop DNA-Guided System for Management of Statin Therapy
3. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
6. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
7. Novavax CEO to Present at BIO Investor Forum 2008
8. Northern Antibiotics Presents New Data on Novel Polymyxin Compounds at the Joint ICAAC/IDSA 2008
9. Peptimmune Presentations at Upcoming Events
10. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
11. Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... 27, 2017 , ... This month Quorum Review IRB ... simplifies research studies, accelerates study startup, and improves participant engagement. Developed by ... the first and only IRB-integrated eConsent solution . , “Our mission at Quorum ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... rebrand and a name change to Fluence Analytics. , Fluence Analytics ... of polymer and biopharmaceutical manufacturing processes and R&D applications. The company’s patented ...
(Date:4/27/2017)... , April 27, 2017  Kinexum, a distinguished resource ... today announces the appointment of Thomas C. Seoh ... ("Zan") Fleming, M.D., Kinexum founder, who becomes Executive Chairman ... to Kinexum clients. Thomas Seoh ... the Kinexum mission and lead the firm,s remarkable team ...
(Date:4/26/2017)... Centennial, CO (PRWEB) , ... April 25, 2017 , ... ... test offerings were added to its extensive test menu: Nucleic Acid Testing (NAT) ... that time, LABS was only able to offer NAT screening for blood donors under ...
Breaking Biology Technology:
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
Breaking Biology News(10 mins):